Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Evaluation of Marketing Interventions in Colombia

21 agosto 2017 aggiornato da: Kathryn Yount, Emory University

Evaluation Of The Effect Of Marketing Interventions For Women On Economic Empowerment And Risk Of Intimate Partner Violence In Colombia

The proposed project seeks to implement a cluster-randomized controlled trial (RCT) to measure the impact of increasing women´s incomes and providing gender equality trainings on women´s empowerment and risk of intimate partner violence (IPV) in Colombia. This project will be the first in Latin America to evaluate rigorously the impact of a marketing intervention, alone and combined with IPV prevention training. The knowledge generated from this evaluation has the potential to identify the most effective solutions to empower women, as well as to drive transformative change in current approaches to reduce IPV and promote gender equality in highly vulnerable populations in Colombia, and worldwide.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Descrizione dettagliata

The proposed project seeks to implement a cluster-randomized controlled trial (RCT) to measure the impact of increasing women´s incomes and providing gender equality trainings on women´s empowerment and risk of intimate partner violence (IPV) in Colombia. This project will be the first in Latin America to evaluate rigorously the impact of a marketing intervention, alone and combined with IPV prevention training. The knowledge generated from this evaluation has the potential to identify the most effective solutions to empower women, as well as to drive transformative change in current approaches to reduce IPV and promote gender equality in highly vulnerable populations in Colombia, and worldwide.

The goal of the project is to estimate the impact of generating livelihood opportunities and providing gender-based violence (GBV) training to reduce IPV among women in Colombia. This will generate much needed evidence on the most effective approach to empower women smallholder farmers and reduce their exposure to IPV. Investigators will conduct a cluster randomized controlled trial targeting approximately 100 smallholder farmers' associations and approximately 2700 women. Results will inform and strengthen future programming of humanitarian assistance and can be replicated in humanitarian interventions in other parts of the world.

The experimental operational research will compare two programmatic modalities and their impact on women's risk of exposure to IPV, against a comparison group where no intervention takes place. The modalities will include: (1) providing a stable income for women, and (2) providing a stable income and IPV trainings to women. The evaluation will take place in five departments: Cauca, Valle de Cauca, Meta, Caquetá, and Nariño.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

1882

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

  • Colombia
    • Bogotá
      • Aurora, Bogotá, Colombia
        • World Food Programme Colombia

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 60 anni (Adulto)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Women currently married or living together with a man as if married
  • Males or females who are active within the farmer's association are eligible to participate

Exclusion Criteria:

  • Women who have a husband/partner who is living elsewhere permanently

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Treatment Group 1
Farmers associations, including men and women, will be randomized to receive the smallholder marketing intervention.
Altro: Smallholder Marketing
The smallholder marketing intervention involves product purchasing (e.g., bananas, beans, goats, eggs) from smallholder farmers' associations through WFP's large procurement procedures. WFP is will also provide technical training on topics such as sustainable farming practices, quality control, and business practices.
Sperimentale: Treatment Group 2
Farmers associations, including men and women, will be randomized to receive the smallholder marketing intervention combined with the intimate partner violence (IPV) prevention training.
Altro: Smallholder Marketing
The smallholder marketing intervention involves product purchasing (e.g., bananas, beans, goats, eggs) from smallholder farmers' associations through WFP's large procurement procedures. WFP is will also provide technical training on topics such as sustainable farming practices, quality control, and business practices.
Altro: Intimate Partner Violence (IPV) Prevention Training
IPV prevention training involves 24 hours of gender training (gender equality and rights, economic empowerment, gender-based violence prevention), and 8 hours of nutrition and food security training (with a focus on gender).
Nessun intervento: Comparison Group 3
Women involved with farmers's associations that work independently of World Food Programmes (WFP's) assistance.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Incidence Physical and/or Sexual IPV
Lasso di tempo: Post-Baseline (12 Months)
The number of new physical and/or sexual IPV encounters as reported in the study survey.
Post-Baseline (12 Months)
Change in Prevalence of Physical and/or Sexual IPV
Lasso di tempo: Baseline, End-Line (12 Months Post Intervention)
The difference in the number of physical or sexual IPV encounters between baseline and post intervention as reported in the study survey.
Baseline, End-Line (12 Months Post Intervention)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Incidence Physical IPV
Lasso di tempo: Post-Baseline (12 Months)
The number of new physical IPV encounters reported.
Post-Baseline (12 Months)
Incidence Sexual IPV
Lasso di tempo: Post-Baseline (12 Months)
The number of new sexual IPV encounters as reported in the study survey.
Post-Baseline (12 Months)
Incidence Psychological IPV
Lasso di tempo: Post-Baseline (12 Months)
The number of new physiological IPV encounters as reported in the study survey.
Post-Baseline (12 Months)
Incidence Economic Coercion
Lasso di tempo: Post-Baseline (12 Months)
The number of new encounters of economic coercion as reported in the study survey.
Post-Baseline (12 Months)
Change in Prevalence of Physical IPV
Lasso di tempo: Baseline, End-Line (12 Months Post Intervention)
The difference in the number of physical IPV encounters between baseline and post intervention as reported in the study survey.
Baseline, End-Line (12 Months Post Intervention)
Change in Prevalence of Sexual IPV
Lasso di tempo: Baseline, End-Line (12 Months Post Intervention)
The difference in the number of sexual IPV encounters between baseline and post intervention as reported in the study survey.
Baseline, End-Line (12 Months Post Intervention)
Change in Prevalence of Psychological IPV
Lasso di tempo: Baseline, End-Line (12 Months Post Intervention)
The difference in the number of psychological IPV encounters between baseline and post intervention as reported in the study survey.
Baseline, End-Line (12 Months Post Intervention)
Change in Prevalence of Economic Coercion
Lasso di tempo: Baseline, End-Line (12 Months Post Intervention)
The difference in the number of economic coercion encounters between baseline and post intervention as reported in the study survey.
Baseline, End-Line (12 Months Post Intervention)

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Women's Attitudes Towards Gender
Lasso di tempo: End-Line (12 Months Post Intervention)
General attitudes towards gender will be qualitatively collected via interview from women post intervention.
End-Line (12 Months Post Intervention)
Change in Women's Economic Empowerment
Lasso di tempo: Baseline, End-Line (12 Months Post Intervention)
Changes in women's thoughts on economic empowerment will be qualitatively collected via interview.
Baseline, End-Line (12 Months Post Intervention)
Change in Women's Attitudes Towards Gender
Lasso di tempo: Baseline, End-Line (12 Months Post Intervention)
Differences in general attitudes towards gender will be qualitatively collected via interview from women from baseline to post intervention.
Baseline, End-Line (12 Months Post Intervention)
Household Food Insecurity
Lasso di tempo: End-Line (12 Months Post Intervention)
Access to adequate amounts of food for the household will be assessed via interview.
End-Line (12 Months Post Intervention)
Change in Household Food Insecurity
Lasso di tempo: Baseline, End-Line (12 Months Post Intervention)
Change in access to adequate amounts of food for the household from baseline to end-line will be assessed via interview.
Baseline, End-Line (12 Months Post Intervention)
Total Personal and Household Income
Lasso di tempo: End-Line (12 Months Post Intervention)
The total income generated for a household will be collected via interview.
End-Line (12 Months Post Intervention)
Change in Total Personal and Household Income
Lasso di tempo: Baseline, End-Line (12 Months Post Intervention)
The difference in the total income generated for a household from baseline to end-line.
Baseline, End-Line (12 Months Post Intervention)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Emory University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

2 aprile 2016

Completamento primario (Effettivo)

31 luglio 2017

Completamento dello studio (Effettivo)

31 luglio 2017

Date di iscrizione allo studio

Primo inviato

5 luglio 2017

Primo inviato che soddisfa i criteri di controllo qualità

5 luglio 2017

Primo Inserito (Effettivo)

7 luglio 2017

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

22 agosto 2017

Ultimo aggiornamento inviato che soddisfa i criteri QC

21 agosto 2017

Ultimo verificato

1 agosto 2017

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • IRB00083606

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Violenza intima del partner

Prove cliniche su Smallholder Marketing

Cerca prove simili

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

CROs by country

CROs in Macedonia

Condizioni

Malattie rare

Interventi farmacologici

Supplementi dietetici

Sponsor / Collaboratori

Sedi

Sottoscrivi